Walter Sunny Dzik1, Alyssa Ziman2, Claudia Cohn3, Menaka Pai4, Miguel Lozano5, Richard M Kaufman6, Meghan Delaney7, Kathleen Selleng8, Michael F Murphy9, Tor Hervig10, Mark Yazer11. 1. Massachusetts General Hospital, Boston, Massachusetts. 2. Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine, UCLA Medical Center, Los Angeles, California. 3. Lab Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, Minnesota. 4. Medicine and Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. 5. Hemotherapy and Hemostasis, University Clinic Hospital, Barcelona, Spain. 6. Pathology, Brigham and Women's Hospital, Boston, Massachusetts. 7. Laboratory Medicine, University of Washington, and Puget Sound Blood Center, Seattle, Washington. 8. Institut for Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany. 9. John Radcliffe Hospital, NHS Blood & Transplant, Oxford, UK. 10. Transfusion Medicine, Haukeland University Hospital, Bergen, Norway. 11. Institute for Transfusion Medicine, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Information about patient survival after transfusion of multiple blood volumes is limited, and most reports have focused on trauma patients. STUDY DESIGN AND METHODS: Retrospective study of blood use and survival at 11 hospitals in six nations between 2009 and 2013. Ultramassive transfusion (UMT) was defined as transfusion of 20 or more red blood cell (RBC) units over the course of any 2 consecutive calendar days. RESULTS: A total of 1975 patients received UMT and a representative sample of 1360 patients was studied in detail. Patients were grouped into seven diagnostic categories: solid organ transplantation (n = 411), cardiac or major vascular surgery (n = 317), general surgery (n = 228), trauma (n = 221), general medicine (n = 124), obstetrics (n = 23), and other (n = 36). During the 7 days after initiation of UMT, these patients used more than 120,000 blood components. The median (interquartile range) blood use was 35 (26-50) RBC units, 30 (20-47) plasma units, and 7 (4-13) platelet doses. Five- and 30-day survival significantly declined with increasing RBC use. Overall survivals of patients receiving UMT were 71% (5 day) and 60% (30 day), and in the subset of 165 patients receiving 60 or more RBC units over 2 consecutive days, 5-day survival was 54% ranging from 17% (trauma) to 75% (solid organ transplant). The decline in survival with increasing RBC transfusions was minimal for patients undergoing solid organ transplantation and was most pronounced for trauma and nonsurgical bleeding patients. CONCLUSION: Trauma was not the leading cause of UMT. Increasing RBC requirements were significantly associated with decreasing survival. However, survival was more strongly associated with diagnostic category than total RBCs transfused, with highest survival rates in solid organ transplant surgery.
BACKGROUND: Information about patient survival after transfusion of multiple blood volumes is limited, and most reports have focused on traumapatients. STUDY DESIGN AND METHODS: Retrospective study of blood use and survival at 11 hospitals in six nations between 2009 and 2013. Ultramassive transfusion (UMT) was defined as transfusion of 20 or more red blood cell (RBC) units over the course of any 2 consecutive calendar days. RESULTS: A total of 1975 patients received UMT and a representative sample of 1360 patients was studied in detail. Patients were grouped into seven diagnostic categories: solid organ transplantation (n = 411), cardiac or major vascular surgery (n = 317), general surgery (n = 228), trauma (n = 221), general medicine (n = 124), obstetrics (n = 23), and other (n = 36). During the 7 days after initiation of UMT, these patients used more than 120,000 blood components. The median (interquartile range) blood use was 35 (26-50) RBC units, 30 (20-47) plasma units, and 7 (4-13) platelet doses. Five- and 30-day survival significantly declined with increasing RBC use. Overall survivals of patients receiving UMT were 71% (5 day) and 60% (30 day), and in the subset of 165 patients receiving 60 or more RBC units over 2 consecutive days, 5-day survival was 54% ranging from 17% (trauma) to 75% (solid organ transplant). The decline in survival with increasing RBC transfusions was minimal for patients undergoing solid organ transplantation and was most pronounced for trauma and nonsurgical bleedingpatients. CONCLUSION:Trauma was not the leading cause of UMT. Increasing RBC requirements were significantly associated with decreasing survival. However, survival was more strongly associated with diagnostic category than total RBCs transfused, with highest survival rates in solid organ transplant surgery.
Authors: Hamilton C Tsang; Annie N Samraj; Ryan J Morse; Niklas Krumm; John R Hess; Monica B Pagano Journal: Blood Transfus Date: 2019-06-05 Impact factor: 3.443
Authors: Meghan Delaney; Paul C Stark; Minhyung Suh; Darrell J Triulzi; John R Hess; Marie E Steiner; Christopher P Stowell; Steven R Sloan Journal: Anesth Analg Date: 2017-06 Impact factor: 5.108
Authors: J C Oldroyd; K M Venardos; N J Aoki; A J Zatta; Z K McQuilten; L E Phillips; N Andrianopoulos; D J Cooper; P A Cameron; J P Isbister; E M Wood Journal: BMC Res Notes Date: 2016-10-06
Authors: Zachary A Matthay; Zane J Hellmann; Rachael A Callcut; Ellicott C Matthay; Brenda Nunez-Garcia; William Duong; Jeffry Nahmias; Aimee K LaRiccia; M Chance Spalding; Satya S Dalavayi; Jessica K Reynolds; Heather Lesch; Yee M Wong; Amanda M Chipman; Rosemary A Kozar; Liz Penaloza; Kaushik Mukherjee; Khaled Taghlabi; Christopher A Guidry; Sirivan S Seng; Asanthi Ratnasekera; Amirreza Motameni; Pascal Udekwu; Kathleen Madden; Sarah A Moore; Jordan Kirsch; Jesse Goddard; James Haan; Kelly Lightwine; Julianne B Ontengco; Daniel C Cullinane; Sarabeth A Spitzer; John C Kubasiak; Joshua Gish; Joshua P Hazelton; Alexandria Z Byskosh; Joseph A Posluszny; Erin E Ross; John J Park; Brittany Robinson; Mary Kathryn Abel; Alexander T Fields; Jonathan H Esensten; Ashok Nambiar; Joanne Moore; Claire Hardman; Pranaya Terse; Xian Luo-Owen; Anquonette Stiles; Brenden Pearce; Kimberly Tann; Khaled Abdul Jawad; Gabriel Ruiz; Lucy Z Kornblith Journal: J Trauma Acute Care Surg Date: 2021-07-01 Impact factor: 3.697